Cysteamine
Back to searchMolecule Structure
Scientific Name
Cysteamine
Description of the Drug
Cysteamine is a cystine depleting agent used to treat the effects of cystinosis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00847
http://www.drugbank.ca/drugs/DB00847
Brand Name(s)
Cystagon, Procysbi
Company Owner(s)
Leadiant Biosciences Inc, Recordati Rare Diseases Inc, Mylan Pharmaceuticals Inc, Horizon Therapeutics Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Cystine | SMALL MOLECULE | REDUCING AGENT | CHEMBL2364039 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL16369 | |||||||||
| PharmGKB | PA449171 | |||||||||
| Human Metabolome Database | HMDB0002991 | |||||||||
| DrugBank | DB00847 | |||||||||
| PubChem: Thomson Pharma | 15218635 | |||||||||
| PubChem | 118985556 | 6058 | ||||||||
| Mcule | MCULE-1838427828 | |||||||||
| NMRShiftDB | 60020697 | |||||||||
| Nikkaji | J62.801H | |||||||||
| PDBe | DHL | |||||||||
| BindingDB | 7968 | |||||||||
| EPA CompTox Dashboard | DTXSID3022875 | |||||||||
| DrugCentral | 768 | |||||||||
| Metabolights | MTBLC17141 | |||||||||
| Brenda | 44877 | 104842 | 56950 | 15839 | 35109 | 29810 | 18187 | 6431 | 787 | 96758 |
| ChemicalBook | CB2223766 | |||||||||
| Guide to Pharmacology | 7440 | |||||||||
| rxnorm | CYSTEAMINE | CYSTEAMINE BITARTRATE | CYSTEAMINE HYDROCHLORIDE | PROCYSBI | CYSTAGON | CYSTARAN | ||||
| KEGG Ligand | C01678 | |||||||||
| ChEBI | 17141 | |||||||||
| ZINC | ZINC000008034121 |
